Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645203 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
A Phase 2 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 2
- Development phase
- 447
- Enrollment target
NCT00645203 is a Phase 2 study that has completed, run by Abbott. The registered enrollment target is 447 participants.
The verdict
NCT00645203, a Phase 2 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 447 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.
Interventions
- DRUG cefdinir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2002-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00645203
The ClinicalTrials.gov registry entry for NCT00645203 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cefdinir is the first listed.
NCT00645203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00645203 about?
NCT00645203 is a clinical study titled "Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media". To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.
What is the current status of trial NCT00645203?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 447 participants. The study started on 2002-07.
What interventions are being tested in trial NCT00645203?
The interventions under investigation include: cefdinir (DRUG).
Who is sponsoring clinical trial NCT00645203?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.